{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:19:33Z","timestamp":1787494773420,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00508-018-1419-8","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T04:03:57Z","timestamp":1555041837000},"page":"91-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Gestationsdiabetes (GDM) (Update 2019)","Gestational diabetes mellitus (Update 2019)"],"prefix":"10.1007","volume":"131","author":[{"given":"Alexandra","family":"Kautzky-Willer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Harreiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Winhofer-St\u00f6ckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Bancher-Todesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Repa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Lechleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimund","family":"Weitgasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"issue":"9677","key":"1419_CR1","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","volume":"373","author":"L Bellamy","year":"2009","unstructured":"Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a\u00a0systematic review and meta-analysis. Lancet. 2009;373(9677):1773\u20139. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)60731-5\n                    \n                  .","journal-title":"Lancet"},{"issue":"9677","key":"1419_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(09)60515-8","volume":"373","author":"EA Reece","year":"2009","unstructured":"Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a\u00a0common ground. Lancet. 2009;373(9677):1789\u201397. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)60515-8\n                    \n                  .","journal-title":"Lancet"},{"issue":"24","key":"1419_CR3","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa042973","volume":"352","author":"CA Crowther","year":"2005","unstructured":"Crowther CA, Hiller JE, Moss JR, et\u00a0al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N\u00a0Engl J Med. 2005;352(24):2477\u201386. \n                    https:\/\/doi.org\/10.1056\/NEJMoa042973\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1419_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003395.pub2","author":"N Alwan","year":"2009","unstructured":"Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database Syst Rev. 2009; \n                    https:\/\/doi.org\/10.1002\/14651858.CD003395.pub2\n                    \n                  .","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1419_CR5","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1210\/jc.2007-2301","volume":"93","author":"A Kautzky-Willer","year":"2008","unstructured":"Kautzky-Willer A, Bancher-Todesca D, Weitgasser R, et al. The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women. J\u00a0Clin Endocrinol Metab. 2008;93(5):1689\u201395. \n                    https:\/\/doi.org\/10.1210\/jc.2007-2301\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1419_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1210\/jc.2014-4055","volume":"100","author":"L Bozkurt","year":"2015","unstructured":"Bozkurt L, G\u00f6bl CS, Pfligl L, et\u00a0al. Pathophysiological characteristics and effects of obesity in women with early and late manifestation of gestational diabetes diagnosed by the International Association of Diabetes and Pregnancy Study Groups criteria. J\u00a0Clin Endocrinol Metab. 2015;100(3):1113\u201320. \n                    https:\/\/doi.org\/10.1210\/jc.2014-4055\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1419_CR7","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.2337\/dc16-0200","volume":"39","author":"J Harreiter","year":"2016","unstructured":"Harreiter J, Simmons D, Desoye G, et\u00a0al. IADPSG and WHO 2013 gestational diabetes mellitus criteria identify obese women with marked insulin resistance in early pregnancy. Diabetes Care. 2016;39(7):e90\u2013e2. \n                    https:\/\/doi.org\/10.2337\/dc16-0200\n                    \n                  .","journal-title":"Diabetes Care"},{"key":"1419_CR8","doi-asserted-by":"publisher","first-page":"4587064","DOI":"10.1155\/2018\/4587064","volume":"2018","author":"J Harreiter","year":"2018","unstructured":"Harreiter J, Schindler K, Bancher-Todesca D, et al. Management of pregnant women after bariatric surgery. J\u00a0Obes. 2018;2018:4587064. \n                    https:\/\/doi.org\/10.1155\/2018\/4587064\n                    \n                  .","journal-title":"J Obes"},{"key":"1419_CR9","series-title":"AWMF-Registernummer 057\u2013008","volume-title":"S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge","author":"Deutsche Diabetes Gesellschaft","year":"2018","unstructured":"Deutsche Diabetes Gesellschaft, Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe. S3-Leitlinie Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. 2.\u00a0Aufl. AWMF-Registernummer 057\u2013008. 2018.","edition":"2"},{"issue":"3","key":"1419_CR10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"BE Metzger","year":"2010","unstructured":"Metzger BE, Gabbe SG, Persson B, et\u00a0al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676\u201382. \n                    https:\/\/doi.org\/10.2337\/dc09-1848\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"3","key":"1419_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.diabres.2013.10.012","volume":"103","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a\u00a0World Health Organization guideline. Diabetes Res Clin Pract. 2014;103(3):341\u201363. \n                    https:\/\/doi.org\/10.1016\/j.diabres.2013.10.012\n                    \n                  .","journal-title":"Diabetes Res Clin Pract"},{"issue":"19","key":"1419_CR12","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"BE Metzger","year":"2008","unstructured":"HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et\u00a0al. Hyperglycemia and adverse pregnancy outcomes. N\u00a0Engl J Med. 2008;358(19):1991\u20132002. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0707943\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"2","key":"1419_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2337\/db08-1112","volume":"58","author":"BE Metzger","year":"2009","unstructured":"HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et\u00a0al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453\u20139. \n                    https:\/\/doi.org\/10.2337\/db08-1112\n                    \n                  .","journal-title":"Diabetes"},{"issue":"12","key":"1419_CR14","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1007\/s00125-012-2726-7","volume":"55","author":"CS G\u00f6bl","year":"2012","unstructured":"G\u00f6bl CS, Bozkurt L, Rivic P, et al. A two-step screening algorithm including fasting plasma glucose measurement and a\u00a0risk estimation model is an accurate strategy for detecting gestational diabetes mellitus. Diabetologia. 2012;55(12):3173\u201381. \n                    https:\/\/doi.org\/10.1007\/s00125-012-2726-7\n                    \n                  .","journal-title":"Diabetologia"},{"key":"1419_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fendo.2018.00220","volume":"9","author":"J Harreiter","year":"2018","unstructured":"Harreiter J, Kautzky-Willer A. Sex and gender differences in prevention of type 2 diabetes. Front Endocrinol (Lausanne). 2018;9:220. \n                    https:\/\/doi.org\/10.3389\/fendo.2018.00220\n                    \n                  .","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"1419_CR16","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1210\/jc.2013-2465","volume":"98","author":"I Blumer","year":"2013","unstructured":"Blumer I, Hadar E, Hadden DR, et\u00a0al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab. 2013;98(11):4227\u201349. \n                    https:\/\/doi.org\/10.1210\/jc.2013-2465\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"key":"1419_CR17","volume-title":"Weight gain during pregnancy: reexamining the guidelines","author":"Institute of Medicine","year":"2009","unstructured":"Institute of Medicine. Weight gain during pregnancy: reexamining the guidelines. 2009. \n                    http:\/\/iom.edu\/~\/media\/Files\/Report%20Files\/2009\/Weight-Gain-During-Pregnancy-Reexamining-the-Guidelines\/Report%20Brief%20-%20Weight%20Gain%20During%20Pregnancy.pdf\n                    \n                  . Zugegriffen: 24. Juni 2015."},{"issue":"9","key":"1419_CR18","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2337\/dc17-0369","volume":"40","author":"E Cosson","year":"2017","unstructured":"Cosson E, Baz B, Gary F, et al. Poor reliability and poor adherence to self-monitoring of blood glucose are common in women with gestational diabetes mellitus and may be associated with poor pregnancy outcomes. Diabetes Care. 2017;40(9):1181\u20136. \n                    https:\/\/doi.org\/10.2337\/dc17-0369\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"1","key":"1419_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/AOG.0000000000002101","volume":"130","author":"H Mendez-Figueroa","year":"2017","unstructured":"Mendez-Figueroa H, Schuster M, Maggio L, et al. Gestational diabetes mellitus and frequency of blood glucose monitoring: a randomized controlled trial. Obstet Gynecol. 2017;130(1):163\u201370. \n                    https:\/\/doi.org\/10.1097\/AOG.0000000000002101\n                    \n                  .","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"1419_CR20","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.2337\/dc18-S013","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. 13. Management of diabetes in pregnancy: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S137\u2013S43. \n                    https:\/\/doi.org\/10.2337\/dc18-S013\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"4","key":"1419_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00404-015-3692-3","volume":"292","author":"S Lv","year":"2015","unstructured":"Lv S, Wang J, Xu Y. Safety of insulin analogs during pregnancy: a\u00a0meta-analysis. Arch Gynecol Obstet. 2015;292(4):749\u201356. \n                    https:\/\/doi.org\/10.1007\/s00404-015-3692-3\n                    \n                  .","journal-title":"Arch Gynecol Obstet"},{"key":"1419_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12721","author":"A Milluzzo","year":"2017","unstructured":"Milluzzo A, Tumminia A, Scalisi NM, et\u00a0al. Insulin degludec in the first trimester of pregnancy: report of two cases. J\u00a0Diabetes Investig. 2017; \n                    https:\/\/doi.org\/10.1111\/jdi.12721\n                    \n                  .","journal-title":"J Diabetes Investig"},{"issue":"1","key":"1419_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.17925\/EE.2015.11.01.17","volume":"11","author":"Z Doder","year":"2015","unstructured":"Doder Z, Vanechanos D, Oster M, et al. Insulin glulisine in pregnancy \u2013 experience from clinical trials and post-marketing surveillance. Eur Endocrinol. 2015;11(1):17\u201320. \n                    https:\/\/doi.org\/10.17925\/EE.2015.11.01.17\n                    \n                  .","journal-title":"Eur Endocrinol"},{"issue":"19","key":"1419_CR24","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"Rowan JA, Hague WM, Gao W, et\u00a0al. Metformin versus insulin for the treatment of gestational diabetes. N\u00a0Engl J Med. 2008;358(19):2003\u201315. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0707193\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"7","key":"1419_CR25","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1471-0528.2010.02763.x","volume":"118","author":"H Ijas","year":"2011","unstructured":"Ijas H, Vaarasmaki M, Morin-Papunen L, et al. Metformin should be considered in the treatment of gestational diabetes: a\u00a0prospective randomised study. BJOG. 2011;118(7):880\u20135. \n                    https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02763.x\n                    \n                  .","journal-title":"BJOG"},{"key":"1419_CR26","doi-asserted-by":"publisher","first-page":"h102","DOI":"10.1136\/bmj.h102","volume":"350","author":"M Balsells","year":"2015","unstructured":"Balsells M, Garcia-Patterson A, Sola I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a\u00a0systematic review and meta-analysis. BMJ. 2015;350:h102. \n                    https:\/\/doi.org\/10.1136\/bmj.h102\n                    \n                  .","journal-title":"BMJ"},{"issue":"10","key":"1419_CR27","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2337\/dc11-0660","volume":"34","author":"JA Rowan","year":"2011","unstructured":"Rowan JA, Rush EC, Obolonkin V, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011;34(10):2279\u201384. \n                    https:\/\/doi.org\/10.2337\/dc11-0660\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"4","key":"1419_CR28","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1210\/jc.2017-02419","volume":"103","author":"LGE Hanem","year":"2018","unstructured":"Hanem LGE, Stridsklev S, Juliusson PB, et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J\u00a0Clin Endocrinol Metab. 2018;103(4):1612\u201321. \n                    https:\/\/doi.org\/10.1210\/jc.2017-02419\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1419_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jamapediatrics.2015.74","volume":"169","author":"W Camelo Castillo","year":"2015","unstructured":"Camelo Castillo W, Boggess K, Sturmer T, et\u00a0al. Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes. JAMA Pediatr. 2015;169(5):452\u20138. \n                    https:\/\/doi.org\/10.1001\/jamapediatrics.2015.74\n                    \n                  .","journal-title":"JAMA Pediatr."},{"issue":"17","key":"1419_CR30","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1001\/jama.2018.4072","volume":"319","author":"MV Senat","year":"2018","unstructured":"Senat MV, Affres H, Letourneau A, et\u00a0al. Effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes: a randomized clinical trial. JAMA. 2018;319(17):1773\u201380. \n                    https:\/\/doi.org\/10.1001\/jama.2018.4072\n                    \n                  .","journal-title":"JAMA"},{"key":"1419_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0050-0","author":"A Kautzky-Willer","year":"2018","unstructured":"Kautzky-Willer A, Harreiter J. Needle beats pill in gestational diabetes mellitus. Nat Rev Endocrinol. 2018; \n                    https:\/\/doi.org\/10.1038\/s41574-018-0050-0\n                    \n                  .","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1419_CR32","doi-asserted-by":"publisher","first-page":"244 e1","DOI":"10.1016\/j.ajog.2014.03.005","volume":"211","author":"AL Sutton","year":"2014","unstructured":"Sutton AL, Mele L, Landon MB, et\u00a0al. Delivery timing and cesarean delivery risk in women with mild gestational diabetes mellitus. Am J Obstet Gynecol. 2014;211(3):244 e1\u2013244 e7. \n                    https:\/\/doi.org\/10.1016\/j.ajog.2014.03.005\n                    \n                  .","journal-title":"Am J Obstet Gynecol"},{"key":"1419_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000938.pub2","author":"M Boulvain","year":"2016","unstructured":"Boulvain M, Irion O, Dowswell T, et\u00a0al. Induction of labour at or near term for suspected fetal macrosomia. Cochrane Database Syst Rev. 2016; \n                    https:\/\/doi.org\/10.1002\/14651858.CD000938.pub2\n                    \n                  .","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1419_CR34","doi-asserted-by":"publisher","first-page":"364 e1","DOI":"10.1016\/j.ajog.2015.12.021","volume":"214","author":"N Melamed","year":"2016","unstructured":"Melamed N, Ray JG, Geary M, et\u00a0al. Induction of labor before 40\u00a0weeks is associated with lower rate of cesarean delivery in women with gestational diabetes mellitus. Am J Obstet Gynecol. 2016;214(3):364 e1\u2013364 e8. \n                    https:\/\/doi.org\/10.1016\/j.ajog.2015.12.021\n                    \n                  .","journal-title":"Am J Obstet Gynecol"},{"issue":"4 Pt 1","key":"1419_CR35","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0002-9378(91)90424-P","volume":"165","author":"O Langer","year":"1991","unstructured":"Langer O, Berkus MD, Huff RW, et\u00a0al. Shoulder dystocia: should the fetus weighing greater than or equal to 4000\u202fg be delivered by cesarean section? Am J Obstet Gynecol. 1991;165(4 Pt 1):831\u20137. \n                    https:\/\/doi.org\/10.1016\/0002-9378(91)90424-P\n                    \n                  .","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1419_CR36","first-page":"439","volume":"44","author":"Gesellschaft f\u00fcr Neonatologie und P\u00e4diatrische Intensivmedizin","year":"2003","unstructured":"Gesellschaft f\u00fcr Neonatologie und P\u00e4diatrische Intensivmedizin, Deutsche Gesellschaft f\u00fcr Perinatale Medizin, Deutsche Diabetes Gesellschaft, et\u00a0al.. Betreuung von Neugeborenen diabetischer M\u00fctter. Frauenarzt. 2003;44(4):439\u201341.","journal-title":"Frauenarzt"},{"issue":"2","key":"1419_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-277X.2008.00921.x","volume":"22","author":"IR Chertok","year":"2009","unstructured":"Chertok IR, Raz I, Shoham I, et\u00a0al. Effects of early breastfeeding on neonatal glucose levels of term infants born to women with gestational diabetes. J\u00a0Hum Nutr Diet. 2009;22(2):166\u20139. \n                    https:\/\/doi.org\/10.1111\/j.1365-277X.2008.00921.x\n                    \n                  .","journal-title":"J Hum Nutr Diet"},{"issue":"9","key":"1419_CR38","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2337\/dc06-2361","volume":"30","author":"TA Hillier","year":"2007","unstructured":"Hillier TA, Pedula KL, Schmidt MM, et\u00a0al. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care. 2007;30(9):2287\u201392. \n                    https:\/\/doi.org\/10.2337\/dc06-2361\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"12","key":"1419_CR39","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1210\/jc.2008-0772","volume":"93","author":"RE Ratner","year":"2008","unstructured":"Ratner RE, Christophi CA, Metzger BE, et\u00a0al. Prevention of diabetes in women with a\u00a0history of gestational diabetes: effects of metformin and lifestyle interventions. J\u00a0Clin Endocrinol Metab. 2008;93(12):4774\u20139. \n                    https:\/\/doi.org\/10.1210\/jc.2008-0772\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1419_CR40","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1210\/jc.2014-3761","volume":"100","author":"VR Aroda","year":"2015","unstructured":"Aroda VR, Christophi CA, Edelstein SL, et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J\u00a0Clin Endocrinol Metab. 2015;100(4):1646\u201353. \n                    https:\/\/doi.org\/10.1210\/jc.2014-3761\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1419_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/AOG.0b013e318220e18f","volume":"118","author":"CS G\u00f6bl","year":"2011","unstructured":"G\u00f6bl CS, Bozkurt L, Prikoszovich T, et\u00a0al. Early possible risk factors for overt diabetes after gestational diabetes mellitus. Obstet Gynecol. 2011;118(1):71\u20138. https:\/\/doi.org\/10.1097\/AOG.0b013e318220e18\u202ff.","journal-title":"Obstet Gynecol"},{"issue":"12","key":"1419_CR42","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.2337\/db12-0393","volume":"61","author":"AG Ziegler","year":"2012","unstructured":"Ziegler AG, Wallner M, Kaiser I, et al. Long-term protective effect of lactation on the development of type 2 diabetes in women with recent gestational diabetes mellitus. Diabetes. 2012;61(12):3167\u201371. \n                    https:\/\/doi.org\/10.2337\/db12-0393\n                    \n                  .","journal-title":"Diabetes"},{"issue":"3","key":"1419_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2337\/diacare.29.03.06.dc05-1940","volume":"29","author":"AH Xiang","year":"2006","unstructured":"Xiang AH, Kawakubo M, Kjos SL, et al. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care. 2006;29(3):613\u20137. \n                    https:\/\/doi.org\/10.2337\/diacare.29.03.06.dc05-1940\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"8","key":"1419_CR44","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.2337\/dc08-0706","volume":"31","author":"BR Shah","year":"2008","unstructured":"Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 2008;31(8):1668\u20139. \n                    https:\/\/doi.org\/10.2337\/dc08-0706\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"7","key":"1419_CR45","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1007\/s00125-016-3985-5","volume":"59","author":"P Damm","year":"2016","unstructured":"Damm P, Houshmand-Oeregaard A, Kelstrup L, et al. Gestational diabetes mellitus and long-term consequences for mother and offspring: a\u00a0view from Denmark. Diabetologia. 2016;59(7):1396\u20139. \n                    https:\/\/doi.org\/10.1007\/s00125-016-3985-5\n                    \n                  .","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"1419_CR46","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13\u2013S27. \n                    https:\/\/doi.org\/10.2337\/dc18-S002\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"1","key":"1419_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2217\/whe.13.69","volume":"10","author":"J Harreiter","year":"2014","unstructured":"Harreiter J, Dovjak G, Kautzky-Willer A. Gestational diabetes mellitus and cardiovascular risk after pregnancy. Womens Health (Lond). 2014;10(1):91\u2013108. \n                    https:\/\/doi.org\/10.2217\/whe.13.69\n                    \n                  .","journal-title":"Womens Health (Lond)"},{"key":"1419_CR48","volume-title":"Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO reference number: WHO\/NMH\/MND\/13.2. 2013","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO reference number: WHO\/NMH\/MND\/13.2. 2013. 2013. \n                    http:\/\/www.who.int\/diabetes\/publications\/Hyperglycaemia_In_Pregnancy\/en\/\n                    \n                  . Zugegriffen: 18. Mai 2015."}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-018-1419-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-018-1419-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-018-1419-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T19:19:18Z","timestamp":1586546358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-018-1419-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":48,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1007\/s00508-018-1419-8","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"12 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.\u00a0Kautzky-Willer hat von folgenden Unternehmen, die teils auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen und\/oder Honorare erhalten: AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline Pharma, Eli Lilly, Merck Sharp\u00a0&\u00a0Dohme, Novartis, Novo Nordisk, Roche, Sanofi-Aventis. J.\u00a0Harreiter hat von folgenden Unternehmen, die teils auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen und\/oder Honorare erhalten: AstraZeneca, Novo Nordisk, Takeda. Y.\u00a0Winhofer-St\u00f6ckl hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen\/Honorare erhalten: Sanofi Aventis, Eli Lilly, AstraZeneca, Novartis. M.\u00a0Lechleitner hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Honorare erhalten: AstraZeneca, Bristol-Myers Squibb, Germania Pharmazeutika, GlaxoSmithKline Pharma, Eli Lilly, Medtronic, Merck Sharp\u00a0&\u00a0Dome, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, Takeda. R.\u00a0Weitgasser hat von folgenden Unternehmen, die teils auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen und\/oder Honorare erhalten: Abbott, Allergan, AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk, Roche, Sanofi-Aventis, Servier, Takeda. D.\u00a0Bancher-Todesca, A.\u00a0Berger und A.\u00a0Repa geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}